Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03831126

Stress and Fetal Brain Development

The Impact of Stress on Fetal Brain Development

Status
Recruiting
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The current proposal aims to investigate the impact of acute stress on the fetal autonomic nervous system.

Detailed description

Over the last decades there is growing evidence that increased maternal stress levels lead to an adverse effect on the physiological, metabolic and neuronal development of the fetus during gestation with possible long-lasting effects. Several studies showed that maternal stress also affects fetal endocrine processes during pregnancy and increases the risk for childhood and adult obesity. Thus, the aim of the study is to investigate the effect of acute stress related to the action of the artificial glucocorticoid betamethasone on fetal heart and brain activity. The fetal activity will be measured with biomagnetic sensors.

Conditions

Interventions

TypeNameDescription
DRUGBetamethason Sodium PhosphateFirst measurement: 12-36 hours after betamethasone treatment Second measurement: within five days after betamethasone treatment and two weeks Third measurement (neonatal measurement): 1-8 weeks after birh

Timeline

Start date
2019-02-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2019-02-05
Last updated
2024-05-16

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03831126. Inclusion in this directory is not an endorsement.